<h1>Pharmaceutical company announces IPO opening July 9 with 27.56 crore issue size on BSE SME platform</h1> A pharmaceutical and nutraceutical company headquartered in Navi Mumbai announced its IPO opening on July 9, 2025, with a proposed issue size of 27.56 crores. The shares will be listed on BSE SME platform through 100% book-building process. The company, established in 2019, operates in over 10 countries, primarily in African markets, manufacturing tablets, capsules, syrups, ointments, and injectables. Net proceeds will fund machinery acquisition, working capital requirements, debt repayment, and general corporate purposes. The issue closes on July 11, 2025, with price band of 115-123 per equity share.